Article Details
Retrieved on: 2021-08-16 14:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Earlier this month, Carrick and Swiss pharma giant Roche partnered to evaluate samuraciclib and Roche's giredestrant in CDK4/6i resistant HR+, ...
Article found on: www.pharmalive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here